New Drug Update Part 1

Recorded April 27, 2023. This course is course is valid until April 27, 2026 and may be taken for credit up to that time.

Learning Objectives:1. Identify recent FDA drug communications, including but not limited to, labeling changes, warnings, new indications, new dosage forms and MedWatch alerts. 2. Discuss the new drugs with respect to their pharmacology, pharmacokinetics, approved and unapproved indications. 3. Describe their adverse effects and drug interaction that may affect patient compliance. 4. Compare efficacy, dosage and cost to existing agent 5. Discuss the patient oriented outcomes or evi- dence that may or may not exist for each of the new medications and when they may or may not be appropriate to recommend for selected patients. 6. Compare pharmacotherapy outcomes vs cost/benefit between newly approved agents and existing or lower cost agents.

ACCREDITATION

University Learning Systems is accredited by the Accreditation Council for Pharmacy Education as a Provider of continuing pharmacy education.

California Board of Registered Nursing Provider No. CEP 11409, for 5 contact hours (0.5 CEU).

CE Broker Tracking #: 50-11357

PRINCIPAL AUDIENCE

PHARMACISTS: University Learning Systems reports credit to CPE Monitor. This course provides 5 contact hours (0.5 CEU). Part 1: UAN 0741-0000-22-004-H01-P

ACTIVITY: Knowledge. No Partial credit is awarded. This course is course is valid until April 27, 2025 and may be taken for credit up to that time.

CANADIAN PHARMACISTS: Canadian Council on Continuing Education in Pharmacy (CCCEP) accepts courses accredited by the Accreditation Council for Pharmacy Education (ACPE).

NURSE PRACTITIONERS/NURSES: This course provides 5 contact hours (0.5 CEU) of pharmacotherapeutics / pharmacology requirements for American Nurses Credentialing Center (ANCC) Category 1 Continuing Education Hours. The same hours submitted to renew certification may be submitted to a State Board of Nursing for re-licensure. American Nurses Credentialing Center (ANCC) accepts formally approved continuing education sponsored by organizations accredited or approved by the Accreditation Council for Pharmacy Education (ACPE).

OTHER HEALTH PROFESSIONALS: Please contact your respective board.

PHYSICIANS: This course may be considered for AMA Category 2 credit only.

CANADIAN PHYSICIANS: This course may be considered for AMA Category 2 credit only which may be equivalent to MAINPRO-M2 credits. Please contact your respective board.

PHYSICIAN ASSISTANTS: This course may be considered for AMA Category 2 credit only.